CVT Surgery - Other

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 96%
3. Lung 95%
4. Neoplasms 77%
5. Lung Transplantation 73%
6. Thorax 65%
7. Esophagectomy 65%
8. Robotics 65%
9. Neoplasm Staging 60%
10. Esophageal Neoplasms 51%
11. Transplant Recipients 42%
12. Thymic epithelial tumor 35%
13. Survival 33%
14. Video-Assisted Thoracic Surgery 32%
15. Therapeutics 30%
16. Surgeons 29%
17. Positron-Emission Tomography 29%
18. Lymph Nodes 28%
19. Neoplasm Metastasis 27%
20. Bronchiolitis Obliterans 26%
21. Thymoma 23%
22. Thymectomy 22%
23. Flap Endonucleases 22%
24. Malignant Mesothelioma 22%
25. Biomarkers 21%
26. Recurrence 21%
27. CpG Islands 20%
28. Autoantibodies 20%
29. Diverticulum 19%
30. Databases 19%
31. Positron Emission Tomography Computed Tomography 19%
32. Biopsy 18%
33. Radiotherapy 18%
34. Empyema 17%
35. Adenocarcinoma 17%
36. ferumoxtran-10 17%
37. Small Cell Lung Carcinoma 17%
38. Stomach 17%
39. Gastroesophageal Reflux 17%
40. Myasthenia Gravis 17%
41. Mesothelioma 17%
42. Lymph Node Excision 16%
43. Thoracotomy 16%
44. Checklist 16%
45. Intensity-Modulated Radiotherapy 16%
46. Coccidioidomycosis 16%
47. Burkholderia cepacia 15%
48. DNA Methylation 15%
49. Cystic Fibrosis 15%
50. Superior Vena Cava Syndrome 15%
51. Mediastinoscopy 15%
52. Mucormycosis 15%
53. Tomography 15%
54. Mutation 15%
55. Thoracic Wall 14%
56. Thoracic Surgery 14%
57. Esophageal Squamous Cell Carcinoma 14%
58. Transplants 14%
59. Mortality 14%
60. Chondrosarcoma 13%
61. Minimally Invasive Surgical Procedures 13%
62. Bronchoscopy 13%
63. Itraconazole 13%
64. Radiofrequency Ablation 13%
65. Leiomyoma 12%
66. Fistula 12%
67. Insulin 12%
68. Deoxyglucose 12%
69. Thoracic Duct 12%
70. Infections 12%
71. Tissue Donors 12%
72. Clinical Trials 12%
73. Thymus Neoplasms 12%
74. Torque 12%
75. Length of Stay 12%
76. glycerol-insulin 12%
77. Epithelial Cells 11%
78. Lung Diseases 11%
79. Wounds and Injuries 11%
80. Equipment and Supplies 11%
81. Antibodies 11%
82. Costs and Cost Analysis 11%
83. Public Opinion 11%
84. Morbidity 10%
85. Solitary Pulmonary Nodule 10%
86. Breast Neoplasms 10%
87. Drug Therapy 10%
88. Serum 10%
89. Cause of Death 10%
90. phosphatase-1 kinase 10%
91. Mediastinum 10%
92. imidazolecarboxamide 10%
93. Chylothorax 10%
94. Population 10%
95. Oxygen 10%
96. Multicenter Studies 9%
97. Multidetector Computed Tomography 9%
98. Paraneoplastic Endocrine Syndromes 9%
99. Biostatistics 9%
100. Incidence 9%